<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.1//EN"
  "http://www.w3.org/TR/xhtml11/DTD/xhtml11.dtd">

<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>All You Need to Know About the Non-Inferiority Hypothesis Test</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1>All You Need to Know About the Non-Inferiority Hypothesis Test</h1>
<blockquote>原文：<a href="https://towardsdatascience.com/all-you-need-to-know-about-non-inferiority-test-c58a74ec4cc5?source=collection_archive---------8-----------------------#2024-10-18">https://towardsdatascience.com/all-you-need-to-know-about-non-inferiority-test-c58a74ec4cc5?source=collection_archive---------8-----------------------#2024-10-18</a></blockquote><div><div class="em fe ff fg fh fi"/><div class="fj fk fl fm fn"><div class="ab cb"><div class="ci bh ev ew ex ey"><div/><div><h2 id="216e" class="pw-subtitle-paragraph gn fp fq bf b go gp gq gr gs gt gu gv gw gx gy gz ha hb hc cq dx">A non-inferiority test statistically proves that a new treatment is not worse than the standard by more than a clinically acceptable margin</h2><div><div class="speechify-ignore ab cp"><div class="speechify-ignore bh l"><div class="hd he hf hg hh ab"><div><div class="ab hi"><div><div class="bm" aria-hidden="false"><a href="https://prateekkrjain.medium.com/?source=post_page---byline--c58a74ec4cc5--------------------------------" rel="noopener follow"><div class="l hj hk by hl hm"><div class="l ed"><img alt="Prateek Jain" class="l ep by dd de cx" src="../Images/aca13a91c244dcffc6a4971649af0ce8.png" width="44" height="44" loading="lazy" data-testid="authorPhoto" data-original-src="https://miro.medium.com/v2/resize:fill:88:88/1*EatJidYTij6yKjz6fhQZ0Q.jpeg"/><div class="hn by l dd de em n ho eo"/></div></div></a></div></div><div class="hp ab ed"><div><div class="bm" aria-hidden="false"><a href="https://towardsdatascience.com/?source=post_page---byline--c58a74ec4cc5--------------------------------" rel="noopener follow"><div class="l hq hr by hl hs"><div class="l ed"><img alt="Towards Data Science" class="l ep by br ht cx" src="../Images/a6ff2676ffcc0c7aad8aaf1d79379785.png" width="24" height="24" loading="lazy" data-testid="publicationPhoto" data-original-src="https://miro.medium.com/v2/resize:fill:48:48/1*CJe3891yB1A1mzMdqemkdg.jpeg"/><div class="hn by l br ht em n ho eo"/></div></div></a></div></div></div></div></div><div class="bn bh l"><div class="ab"><div style="flex:1"><span class="bf b bg z bk"><div class="hu ab q"><div class="ab q hv"><div class="ab q"><div><div class="bm" aria-hidden="false"><p class="bf b hw hx bk"><a class="af ag ah ai aj ak al am an ao ap aq ar hy" data-testid="authorName" href="https://prateekkrjain.medium.com/?source=post_page---byline--c58a74ec4cc5--------------------------------" rel="noopener follow">Prateek Jain</a></p></div></div></div><span class="hz ia" aria-hidden="true"><span class="bf b bg z dx">·</span></span><p class="bf b hw hx dx"><button class="ib ic ah ai aj ak al am an ao ap aq ar id ie if" disabled="">Follow</button></p></div></div></span></div></div><div class="l ig"><span class="bf b bg z dx"><div class="ab cn ih ii ij"><div class="ik il ab"><div class="bf b bg z dx ab im"><span class="in l ig">Published in</span><div><div class="l" aria-hidden="false"><a class="af ag ah ai aj ak al am an ao ap aq ar hy ab q" data-testid="publicationName" href="https://towardsdatascience.com/?source=post_page---byline--c58a74ec4cc5--------------------------------" rel="noopener follow"><p class="bf b bg z io ip iq ir is it iu iv bk">Towards Data Science</p></a></div></div></div><div class="h k"><span class="hz ia" aria-hidden="true"><span class="bf b bg z dx">·</span></span></div></div><span class="bf b bg z dx"><div class="ab ae"><span data-testid="storyReadTime">6 min read</span><div class="iw ix l" aria-hidden="true"><span class="l" aria-hidden="true"><span class="bf b bg z dx">·</span></span></div><span data-testid="storyPublishDate">Oct 18, 2024</span></div></span></div></span></div></div></div><div class="ab cp iy iz ja jb jc jd je jf jg jh ji jj jk jl jm jn"><div class="h k w ea eb q"><div class="kd l"><div class="ab q ke kf"><div class="pw-multi-vote-icon ed in kg kh ki"><div class=""><div class="kj kk kl km kn ko kp am kq kr ks ki"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewbox="0 0 24 24" aria-label="clap"><path fill-rule="evenodd" d="M11.37.828 12 3.282l.63-2.454zM15.421 1.84l-1.185-.388-.338 2.5zM9.757 1.452l-1.184.389 1.523 2.112zM20.253 11.84 17.75 7.438c-.238-.353-.57-.584-.93-.643a.96.96 0 0 0-.753.183 1.13 1.13 0 0 0-.443.695c.014.019.03.033.044.053l2.352 4.138c1.614 2.95 1.1 5.771-1.525 8.395a7 7 0 0 1-.454.415c.997-.13 1.927-.61 2.773-1.457 2.705-2.704 2.517-5.585 1.438-7.377M12.066 9.01c-.129-.687.08-1.299.573-1.773l-2.062-2.063a1.123 1.123 0 0 0-1.555 0 1.1 1.1 0 0 0-.273.521z" clip-rule="evenodd"/><path fill-rule="evenodd" d="M14.741 8.309c-.18-.267-.446-.455-.728-.502a.67.67 0 0 0-.533.127c-.146.113-.59.458-.199 1.296l1.184 2.503a.448.448 0 0 1-.236.755.445.445 0 0 1-.483-.248L7.614 6.106A.816.816 0 1 0 6.459 7.26l3.643 3.644a.446.446 0 1 1-.631.63L5.83 7.896l-1.03-1.03a.82.82 0 0 0-1.395.577.81.81 0 0 0 .24.576l1.027 1.028 3.643 3.643a.444.444 0 0 1-.144.728.44.44 0 0 1-.486-.098l-3.64-3.64a.82.82 0 0 0-1.335.263.81.81 0 0 0 .178.89l1.535 1.534 2.287 2.288a.445.445 0 0 1-.63.63l-2.287-2.288a.813.813 0 0 0-1.393.578c0 .216.086.424.238.577l4.403 4.403c2.79 2.79 5.495 4.119 8.681.931 2.269-2.271 2.708-4.588 1.342-7.086z" clip-rule="evenodd"/></svg></div></div></div><div class="pw-multi-vote-count l kt ku kv kw kx ky kz"><p class="bf b dy z dx"><span class="kk">--</span></p></div></div></div><div><div class="bm" aria-hidden="false"><button class="ao kj la lb ab q ee lc ld" aria-label="responses"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewbox="0 0 24 24" class="le"><path d="M18.006 16.803c1.533-1.456 2.234-3.325 2.234-5.321C20.24 7.357 16.709 4 12.191 4S4 7.357 4 11.482c0 4.126 3.674 7.482 8.191 7.482.817 0 1.622-.111 2.393-.327.231.2.48.391.744.559 1.06.693 2.203 1.044 3.399 1.044.224-.008.4-.112.486-.287a.49.49 0 0 0-.042-.518c-.495-.67-.845-1.364-1.04-2.057a4 4 0 0 1-.125-.598zm-3.122 1.055-.067-.223-.315.096a8 8 0 0 1-2.311.338c-4.023 0-7.292-2.955-7.292-6.587 0-3.633 3.269-6.588 7.292-6.588 4.014 0 7.112 2.958 7.112 6.593 0 1.794-.608 3.469-2.027 4.72l-.195.168v.255c0 .056 0 .151.016.295.025.231.081.478.154.733.154.558.398 1.117.722 1.659a5.3 5.3 0 0 1-2.165-.845c-.276-.176-.714-.383-.941-.59z"/></svg></button></div></div></div><div class="ab q jo jp jq jr js jt ju jv jw jx jy jz ka kb kc"><div class="lf k j i d"/><div class="h k"><div><div class="bm" aria-hidden="false"><button aria-controls="addToCatalogBookmarkButton" aria-expanded="false" aria-label="Add to list bookmark button" data-testid="headerBookmarkButton" class="af ee ah ai aj ak al lg an ao ap id lh li lj" disabled=""><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" fill="none" viewbox="0 0 24 24" class="av"><path fill="#000" d="M17.5 1.25a.5.5 0 0 1 1 0v2.5H21a.5.5 0 0 1 0 1h-2.5v2.5a.5.5 0 0 1-1 0v-2.5H15a.5.5 0 0 1 0-1h2.5zm-11 4.5a1 1 0 0 1 1-1H11a.5.5 0 0 0 0-1H7.5a2 2 0 0 0-2 2v14a.5.5 0 0 0 .8.4l5.7-4.4 5.7 4.4a.5.5 0 0 0 .8-.4v-8.5a.5.5 0 0 0-1 0v7.48l-5.2-4a.5.5 0 0 0-.6 0l-5.2 4z"/></svg></button></div></div></div><div class="ep lk cn"><div class="l ae"><div class="ab cb"><div class="ll lm ln lo lp lq ci bh"><div class="ab"><div class="bm bh" aria-hidden="false"><div><div class="bm" aria-hidden="false"><button aria-label="Listen" data-testid="audioPlayButton" class="af ee ah ai aj ak al lg an ao ap id lr ls ld lt lu lv lw lx s ly lz ma mb mc md me u mf mg mh"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" fill="none" viewbox="0 0 24 24"><path fill="currentColor" fill-rule="evenodd" d="M3 12a9 9 0 1 1 18 0 9 9 0 0 1-18 0m9-10C6.477 2 2 6.477 2 12s4.477 10 10 10 10-4.477 10-10S17.523 2 12 2m3.376 10.416-4.599 3.066a.5.5 0 0 1-.777-.416V8.934a.5.5 0 0 1 .777-.416l4.599 3.066a.5.5 0 0 1 0 .832" clip-rule="evenodd"/></svg><div class="j i d"><p class="bf b bg z dx">Listen</p></div></button></div></div></div></div></div></div></div></div><div class="bm" aria-hidden="false" aria-describedby="postFooterSocialMenu" aria-labelledby="postFooterSocialMenu"><div><div class="bm" aria-hidden="false"><button aria-controls="postFooterSocialMenu" aria-expanded="false" aria-label="Share Post" data-testid="headerSocialShareButton" class="af ee ah ai aj ak al lg an ao ap id lr ls ld lt lu lv lw lx s ly lz ma mb mc md me u mf mg mh"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" fill="none" viewbox="0 0 24 24"><path fill="currentColor" fill-rule="evenodd" d="M15.218 4.931a.4.4 0 0 1-.118.132l.012.006a.45.45 0 0 1-.292.074.5.5 0 0 1-.3-.13l-2.02-2.02v7.07c0 .28-.23.5-.5.5s-.5-.22-.5-.5v-7.04l-2 2a.45.45 0 0 1-.57.04h-.02a.4.4 0 0 1-.16-.3.4.4 0 0 1 .1-.32l2.8-2.8a.5.5 0 0 1 .7 0l2.8 2.79a.42.42 0 0 1 .068.498m-.106.138.008.004v-.01zM16 7.063h1.5a2 2 0 0 1 2 2v10a2 2 0 0 1-2 2h-11c-1.1 0-2-.9-2-2v-10a2 2 0 0 1 2-2H8a.5.5 0 0 1 .35.15.5.5 0 0 1 .15.35.5.5 0 0 1-.15.35.5.5 0 0 1-.35.15H6.4c-.5 0-.9.4-.9.9v10.2a.9.9 0 0 0 .9.9h11.2c.5 0 .9-.4.9-.9v-10.2c0-.5-.4-.9-.9-.9H16a.5.5 0 0 1 0-1" clip-rule="evenodd"/></svg><div class="j i d"><p class="bf b bg z dx">Share</p></div></button></div></div></div><div class="bm" aria-hidden="false"><div><div class="bm" aria-hidden="false"><button aria-label="More options" data-testid="headerStoryOptionsButton" class="af ee ah ai aj ak al lg an ao ap id lr ls ld lt lu lv lw lx s ly lz ma mb mc md me u mf mg mh"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" fill="none" viewbox="0 0 24 24"><path fill="currentColor" fill-rule="evenodd" d="M4.385 12c0 .55.2 1.02.59 1.41.39.4.86.59 1.41.59s1.02-.2 1.41-.59c.4-.39.59-.86.59-1.41s-.2-1.02-.59-1.41a1.93 1.93 0 0 0-1.41-.59c-.55 0-1.02.2-1.41.59-.4.39-.59.86-.59 1.41m5.62 0c0 .55.2 1.02.58 1.41.4.4.87.59 1.42.59s1.02-.2 1.41-.59c.4-.39.59-.86.59-1.41s-.2-1.02-.59-1.41a1.93 1.93 0 0 0-1.41-.59c-.55 0-1.03.2-1.42.59s-.58.86-.58 1.41m5.6 0c0 .55.2 1.02.58 1.41.4.4.87.59 1.43.59s1.03-.2 1.42-.59.58-.86.58-1.41-.2-1.02-.58-1.41a1.93 1.93 0 0 0-1.42-.59c-.56 0-1.04.2-1.43.59s-.58.86-.58 1.41" clip-rule="evenodd"/></svg><div class="j i d"><p class="bf b bg z dx">More</p></div></button></div></div></div></div></div></div></div></div></div><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div role="button" tabindex="0" class="mr ms ed mt bh mu"><div class="mi mj mk"><img src="../Images/59b1f94df176dbf50e72c65b6838f2d3.png" data-original-src="https://miro.medium.com/v2/resize:fit:1400/format:webp/1*OflsESN0X691cs1ujDpJuA.jpeg"/></div></div><figcaption class="mw mx my mi mj mz na bf b bg z dx">Generated using Midjourney by <a class="af nb" href="http://prateekkrjain.com" rel="noopener ugc nofollow" target="_blank">prateekkrjain.com</a></figcaption></figure><p id="ad83" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">While working on a recent problem, I encountered a familiar challenge — <strong class="ne fr">“How can we determine if a new treatment or intervention is at least as effective as a standard treatment?”</strong> At first glance, the solution seemed straightforward — just compare their averages, right? But as I dug deeper, I realised it wasn’t that simple. In many cases, the goal isn’t to prove that the new treatment is better, but to show that it’s <em class="ny">not worse</em> by more than a predefined margin.</p><p id="e5bc" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">This is where <strong class="ne fr">non-inferiority tests</strong> come into play. These tests allow us to demonstrate that the new treatment or method is “not worse” than the control by more than a small, acceptable amount. Let’s take a deep dive into how to perform this test and, most importantly, how to interpret it under different scenarios.</p><h1 id="b94e" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">The Concept of Non-Inferiority Testing</h1><p id="59d5" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">In non-inferiority testing, we’re not trying to prove that the new treatment is better than the existing one. Instead, we’re looking to show that the new treatment is <strong class="ne fr">not unacceptably worse</strong>. The threshold for what constitutes “unacceptably worse” is known as the <strong class="ne fr">non-inferiority margin</strong> (Δ). For example, if Δ=5, the new treatment can be up to 5 units worse than the standard treatment, and we’d still consider it acceptable.</p><p id="8cc2" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">This type of analysis is particularly useful when the new treatment might have other advantages, such as being cheaper, safer, or easier to administer.</p><h1 id="4c97" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">Formulating the Hypotheses</h1><p id="56d7" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">Every non-inferiority test starts with formulating two hypotheses:</p><ul class=""><li id="7795" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">Null Hypothesis (H0​)</strong>: The new treatment is worse than the standard treatment by more than the non-inferiority margin Δ.</li><li id="fe59" class="nc nd fq ne b go pd ng nh gr pe nj nk nl pf nn no np pg nr ns nt ph nv nw nx pa pb pc bk"><strong class="ne fr">Alternative Hypothesis (H1​)</strong>: The new treatment is not worse than the standard treatment by more than Δ.</li></ul><h2 id="dd5c" class="pi oa fq bf ob pj pk pl oe pm pn po oh nl pp pq pr np ps pt pu nt pv pw px py bk">When Higher Values Are Better:</h2><p id="ea5a" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">For example, when we are measuring something like drug efficacy, where <strong class="ne fr">higher values are better</strong>, the hypotheses would be:</p><ul class=""><li id="058f" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">H0​</strong>: The new treatment is worse than the standard treatment by at least Δ (i.e., μnew − μcontrol ≤ −Δ).</li><li id="1404" class="nc nd fq ne b go pd ng nh gr pe nj nk nl pf nn no np pg nr ns nt ph nv nw nx pa pb pc bk"><strong class="ne fr">H1​</strong>: The new treatment is <strong class="ne fr">not</strong> worse than the standard treatment by more than Δ (i.e., μnew − μcontrol &gt; −Δ).</li></ul><h2 id="2cc3" class="pi oa fq bf ob pj pk pl oe pm pn po oh nl pp pq pr np ps pt pu nt pv pw px py bk">When Lower Values Are Better:</h2><p id="c2f2" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">On the other hand, when <strong class="ne fr">lower values are better</strong>, like when we are measuring side effects or error rates, the hypotheses are reversed:</p><ul class=""><li id="f500" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">H0</strong>: The new treatment is worse than the standard treatment by at least Δ (i.e., μnew − μcontrol ≥ Δ).</li><li id="a0b5" class="nc nd fq ne b go pd ng nh gr pe nj nk nl pf nn no np pg nr ns nt ph nv nw nx pa pb pc bk"><strong class="ne fr">H1​</strong>: The new treatment is <strong class="ne fr">not</strong> worse than the standard treatment by more than Δ (i.e., μnew − μcontrol &lt; Δ).</li></ul><h1 id="44c6" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">Z-Statistic</h1><p id="94bb" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">To perform a non-inferiority test, we calculate the <strong class="ne fr">Z-statistic</strong>, which measures how far the observed difference between treatments is from the non-inferiority margin. Depending on whether <strong class="ne fr">higher or lower values are better</strong>, the formula for the Z-statistic will differ.</p><ul class=""><li id="09b5" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk">When <strong class="ne fr">higher values are better</strong>:</li></ul><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div class="mi mj pz"><img src="../Images/008996de27836a2699e4af582d105b44.png" data-original-src="https://miro.medium.com/v2/resize:fit:512/format:webp/1*WNme32ZPXhskXS7OjvqucA.png"/></div></figure><ul class=""><li id="067d" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk">When <strong class="ne fr">lower values are better</strong>:</li></ul><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div class="mi mj qa"><img src="../Images/29ab6915089d2d249a21e2b115e1059c.png" data-original-src="https://miro.medium.com/v2/resize:fit:572/format:webp/1*lD_jCH_VxeUkPyj6-aDcSQ.png"/></div></figure><p id="e82b" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">where δ is the observed difference in means between the new and standard treatments, and SE(δ) is the standard error of that difference.</p><h1 id="dae9" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">Calculating P-Values</h1><p id="2a80" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">The <strong class="ne fr">p-value</strong> tells us whether the observed difference between the new treatment and the control is statistically significant in the context of the non-inferiority margin. Here’s how it works in different scenarios:</p><ul class=""><li id="4437" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">When higher values are better</strong>, we calculate <br/> p = 1 − P(Z ≤ calculated Z) <br/>as we are testing if the new treatment is not worse than the control (one-sided upper-tail test).</li><li id="8c83" class="nc nd fq ne b go pd ng nh gr pe nj nk nl pf nn no np pg nr ns nt ph nv nw nx pa pb pc bk"><strong class="ne fr">When lower values are better</strong>, we calculate <br/> p = P(Z ≤ calculated Z)<br/>since we are testing whether the new treatment has lower (better) values than the control (one-sided lower-tail test).</li></ul><h1 id="0af5" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">Understanding Confidence Intervals</h1><p id="916f" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">Along with the p-value, <strong class="ne fr">confidence intervals</strong> provide another key way to interpret the results of a non-inferiority test.</p><ul class=""><li id="8a5d" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk">When <strong class="ne fr">higher values are preferred</strong>, we focus on the <strong class="ne fr">lower bound</strong> of the confidence interval. If it’s greater than −Δ, we conclude non-inferiority.</li><li id="31ed" class="nc nd fq ne b go pd ng nh gr pe nj nk nl pf nn no np pg nr ns nt ph nv nw nx pa pb pc bk">When <strong class="ne fr">lower values are preferred</strong>, we focus on the <strong class="ne fr">upper bound</strong> of the confidence interval. If it’s less than Δ, we conclude non-inferiority.</li></ul><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div role="button" tabindex="0" class="mr ms ed mt bh mu"><div class="mi mj qb"><img src="../Images/a0ed59a09bf5c0e251322069c9f151ce.png" data-original-src="https://miro.medium.com/v2/resize:fit:1400/format:webp/1*Q_QLq6kRhiK_yhRRywID-w.png"/></div></div></figure><p id="7abf" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">The confidence interval is calculated using the formula:</p><ul class=""><li id="87a8" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">when higher values preferred</strong></li></ul><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div class="mi mj qc"><img src="../Images/1c93924d62d01194a4f9be3eb2b13342.png" data-original-src="https://miro.medium.com/v2/resize:fit:1016/format:webp/1*UM0-QnMSl34ZTv5JkmeKFw.png"/></div></figure><ul class=""><li id="f42c" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">when lower values preferred</strong></li></ul><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div class="mi mj qd"><img src="../Images/79945d242cd4f366a787b44e3779a4bf.png" data-original-src="https://miro.medium.com/v2/resize:fit:1076/format:webp/1*g_LaNfqNv93BurFxojFCqw.png"/></div></figure><h1 id="9dfa" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">Calculating the Standard Error (SE)</h1><p id="ba71" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">The <strong class="ne fr">standard error (SE)</strong> measures the variability or precision of the estimated difference between the means of two groups, typically the new treatment and the control. It is a critical component in the calculation of the Z-statistic and the confidence interval in non-inferiority testing.</p><p id="8e84" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">To calculate the standard error for the difference in means between two independent groups, we use the following formula:</p><ul class=""><li id="0634" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">between two means</strong></li></ul><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div class="mi mj qe"><img src="../Images/56394ccf3fcc97646693433986efed91.png" data-original-src="https://miro.medium.com/v2/resize:fit:1008/format:webp/1*WRHsuFHcDp_SrrSQv2aR9g.png"/></div></figure><ul class=""><li id="aff4" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">between two proportions</strong></li></ul><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div role="button" tabindex="0" class="mr ms ed mt bh mu"><div class="mi mj qf"><img src="../Images/d224246324d0d88892d1d921da1ef160.png" data-original-src="https://miro.medium.com/v2/resize:fit:1400/format:webp/1*Xr3H_uhmyo8h3p9VF2jlbw.png"/></div></div></figure><p id="8628" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">Where:</p><ul class=""><li id="3438" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk"><strong class="ne fr">σ_new</strong> and <strong class="ne fr">σ_control</strong> are the standard deviations of the new and control groups.</li><li id="dabf" class="nc nd fq ne b go pd ng nh gr pe nj nk nl pf nn no np pg nr ns nt ph nv nw nx pa pb pc bk"><strong class="ne fr">p_new</strong> and <strong class="ne fr">p_control</strong> are the proportion of success of the new and control groups.</li><li id="1822" class="nc nd fq ne b go pd ng nh gr pe nj nk nl pf nn no np pg nr ns nt ph nv nw nx pa pb pc bk"><strong class="ne fr">n_new</strong>​ and <strong class="ne fr">n_control</strong> are the sample sizes of the new and control groups.</li></ul><h1 id="4170" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">The Role of Alpha (<strong class="al">α</strong>)</h1><p id="63e0" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">In hypothesis testing, <strong class="ne fr">α</strong> (the significance level) determines the threshold for rejecting the null hypothesis. For most non-inferiority tests, <strong class="ne fr">α=0.05</strong> (5% significance level) is used.</p><ul class=""><li id="fa38" class="nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx pa pb pc bk">A <strong class="ne fr">one-sided test</strong> with α=0.05 corresponds to a critical <strong class="ne fr">Z-value of 1.645</strong>. This value is crucial in determining whether to reject the null hypothesis.</li><li id="d39f" class="nc nd fq ne b go pd ng nh gr pe nj nk nl pf nn no np pg nr ns nt ph nv nw nx pa pb pc bk">The <strong class="ne fr">confidence interval</strong> is also based on this Z-value. For a 95% confidence interval, we use <strong class="ne fr">1.645</strong> as the multiplier in the confidence interval formula.</li></ul><p id="0fdc" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">In simple terms, if your <strong class="ne fr">Z-statistic</strong> is greater than <strong class="ne fr">1.645</strong> for higher values, or less than <strong class="ne fr">-1.645</strong> for lower values, and the confidence interval bounds support non-inferiority, then you can confidently reject the null hypothesis and conclude that the new treatment is <strong class="ne fr">non-inferior</strong>.</p><h1 id="25d8" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">Interpretation</h1><p id="2aa1" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">Let’s break down the interpretation of the <strong class="ne fr">Z-statistic</strong> and <strong class="ne fr">confidence intervals</strong> across four key scenarios, based on whether higher or lower values are preferred and whether the Z-statistic is positive or negative.</p><p id="587d" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk"><strong class="ne fr">Here’s a 2x2 framework:</strong></p><figure class="ml mm mn mo mp mq mi mj paragraph-image"><div role="button" tabindex="0" class="mr ms ed mt bh mu"><div class="mi mj qg"><img src="../Images/4c150c7ad20852df31caa24a7c1d93ab.png" data-original-src="https://miro.medium.com/v2/resize:fit:1400/format:webp/1*sC_KlIwPkkF0CwBflxWJmg.png"/></div></div></figure><h1 id="6634" class="nz oa fq bf ob oc od gq oe of og gt oh oi oj ok ol om on oo op oq or os ot ou bk">Conclusion</h1><p id="8946" class="pw-post-body-paragraph nc nd fq ne b go ov ng nh gr ow nj nk nl ox nn no np oy nr ns nt oz nv nw nx fj bk">Non-inferiority tests are invaluable when you want to demonstrate that a new treatment is not significantly worse than an existing one. Understanding the nuances of Z-statistics, p-values, confidence intervals, and the role of α will help you confidently interpret your results. Whether higher or lower values are preferred, the framework we’ve discussed ensures that you can make clear, evidence-based conclusions about the effectiveness of your new treatment.</p><p id="cba8" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">Now that you’re equipped with the knowledge of how to perform and interpret non-inferiority tests, you can apply these techniques to a wide range of real-world problems.</p><p id="88f5" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk">Happy testing!</p><p id="ac0e" class="pw-post-body-paragraph nc nd fq ne b go nf ng nh gr ni nj nk nl nm nn no np nq nr ns nt nu nv nw nx fj bk"><em class="ny">Note: All images, unless otherwise noted, are by the author.</em></p></div></div></div></div>    
</body>
</html>